Trending
August 9, 2024

Amneal Reports Second Quarter 2024 Financial Results

August 9, 2024

Mind Medicine Proposed Public Offering

August 9, 2024

Merck to Acquire Investigational B-Cell Depletion Therapy, CN201, from Curon Biopharmaceutical

August 9, 2024

IDRx Raises $120M in Series B Led by RA Capital, Commodore and Blackstone

August 8, 2024

Insmed Reports Second-Quarter 2024 Financial Results and Provides Business Update

August 8, 2024

Consello Capital Acquires EHE Health

August 8, 2024

DarioHealth Reports Second Quarter 2024 Financial and Operating Results

August 8, 2024

Immunic Reports Second Quarter 2024 Financial Results and Provides Corporate Update

August 7, 2024

Chromocell Announces Stock Repurchase Plan

August 7, 2024

Intra-Cellular Therapies Appoints Sanjeev Narula as Chief Financial Officer

August 7, 2024

Cellectis Appoints Dr. Adrian Kilcoyne as Chief Medical Officer

August 7, 2024

New York-New Jersey Area Comes Fourth in Ranking of Biopharma Clusters

August 6, 2024

Melinta Therapeutics Appoints Fabrizio Tondolo, MD, as Vice President of Medical Affairs

August 6, 2024

HealthCare Royalty and Blue Owl Announce $250M Debt Financing with TG Therapeutics

August 6, 2024

BioXcel Therapeutics Reports Second Quarter 2024 Financial Results

August 5, 2024

Citius Pharmaceuticals Announces TenX Keane Shareholder Approval of Merger with Citius Oncology